Clinical Trial Update: Bevacizumab and Capecitabine in Treatment of Elderly Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with capecitabine in elderly patients with metastatic breast cancer. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Xeloda (capecitabine)

Snippet

Sponsor: South Eastern European Research Oncology Group | Conditions: Breast Cancer, Metastasis | Phase 2 | Status: UNKNOWN